ABCEurope Infection & Immunity Technology Showcase
European researchers from academia and SMEs will be presenting their innovative technologies in the field of infectious diseases and immunity - which are available for licensing or collaborative research projects.
Programme:
14.00 - Welcome and Introduction, Prof. Colin R. Howard
14.15 - “Encaging the pro-inflammatory danger by natural humoral immunity”
Dr Anna Frostegård, Medirista Biotechnologies, Sweden
14.35 - “Immunotherapy of Cancer and Chronic Infection”
Prof. Hans Stauss, UCL, UK
14.55 - “Development of a novel food ingredient for the prevention of rotavirus infections”
Prof. David Lembo, Rotalactis, Italy
15.15 - “Development of novel antibiotic technology”
Dr Heather Fairhead, Phico Therapeutics, UK
15.35 - Coffee break
16.00 - “Detection and monitoring of industrial workers for allergic rhinitis and asthma”
Dr Paul Rodgers, ProteinLogic, UK
16.20 - “Identification of a novel gene expression-based biomarker that predicts prognosis in autoimmune and inflammatory disease”
Dr Paul Lyons, University of Cambridge, UK
16.40 - “A new concept in cancer vaccine immune monitoring: The detection of new immune response and epitope spreading under vaccination via peptide arrays”
Dr Paul von Hoegen, JPT Peptide Technologies, Germany
17.00 - “Development of a novel peptide for decolonisation of MRSA carriage”
Dr Mathew Upton, University of Manchester, UK
17.20 - Conclusions,
Prof. Ken Powell
Please note that attendance at this event is free. However, this does NOT give you access to Genesis. Whether you are a Genesis delegate or would like to attend this event only, it will be vital to register on line. Please
click here to register.
The target audience for this event are R&D companies, academics and investors only. Any other attendees in another business field will need to register for Genesis in order to attend this technology showcase event.